Allergy & Immunology
Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?
12 Aug, 2020 | 02:38h | UTCAntibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit? – Nature
Related: Antibody drugs could be one of the best weapons against Covid-19. But will they matter? – STAT AND Designer antibodies could battle COVID-19 before vaccines arrive – Science
Russia has approved ‘world first’ Covid-19 vaccine. But questions over its safety remain
12 Aug, 2020 | 02:28h | UTCSee also: Russia has launched the world’s first COVID-19 vaccine: Here’s all you need to know – Firstpost AND Coronavirus: Putin says vaccine has been approved for use – BBC AND Russia Approves Coronavirus Vaccine Before Completing Tests – The New York Times AND The Russian Vaccine – Science Translational Medicine AND Russia claims first coronavirus vaccine as global cases top 20 million – MedicalXpress
[Preprint] Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: Report of the randomized, double-blind, and placebo-controlled phase 2 clinical trial
11 Aug, 2020 | 10:19h | UTC
Commentary on Twitter
https://twitter.com/hildabast/status/1293062320319426560
The Coronavirus is new, but your immune system might still recognize it
10 Aug, 2020 | 01:59h | UTCThe Coronavirus Is New, but Your Immune System Might Still Recognize It – The New York Times
ATS Guideline: Diagnosis of hypersensitivity pneumonitis in adults
7 Aug, 2020 | 03:09h | UTC
Perspective: Immunology is where intuition goes to die
6 Aug, 2020 | 02:56h | UTCImmunology Is Where Intuition Goes to Die – The Atlantic
Review: T cell responses in patients with COVID-19
6 Aug, 2020 | 02:57h | UTCT cell responses in patients with COVID-19 – Nature Reviews Immunology
Nine important things we’ve learned about the Coronavirus pandemic so far
5 Aug, 2020 | 10:14h | UTCNine Important Things We’ve Learned about the Coronavirus Pandemic So Far – Scientific American
SARS-CoV-2 (COVID-19) serology: Implications for clinical practice, laboratory medicine and public health
5 Aug, 2020 | 10:06h | UTC
Commentary on Twitter
Serology testing for SARS-CoV-2 will be useful for public health decisions and research but will not have wide application for clinical care based on current evidence, according to a new review by representatives of five expert groups: https://t.co/Z3TOZrbhi0 pic.twitter.com/1wHg5Ql78K
— CMAJ (@CMAJ) August 4, 2020
Those with milder COVID-19 may not shed live virus as long
5 Aug, 2020 | 10:04h | UTCThose with milder COVID-19 may not shed live virus as long – CIDRAP
Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2
5 Aug, 2020 | 09:58h | UTCOriginal Study: Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans – Science
Coronavirus vaccine tracker: How close are we to a vaccine?
5 Aug, 2020 | 10:00h | UTCCoronavirus vaccine tracker: how close are we to a vaccine? – The Guardian
Related: Coronavirus Vaccine Tracker – The New York Times
[Preprint] REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters
5 Aug, 2020 | 09:56h | UTCCommentaries: Regeneron’s Monoclonal Antibody Cocktail in Primates – Science Translational Medicine AND Regeneron antibody cocktail shows promise as potential COVID-19 treatment – News Medical
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
4 Aug, 2020 | 03:01h | UTCCommentary: Ancient part of immune system may underpin severe COVID – Columbia University Irving Medical Center
Commentary on Twitter
https://twitter.com/nresearchnews/status/1290308064185180160
Editorial: Cellular immune responses to Covid-19
3 Aug, 2020 | 01:06h | UTCCellular immune responses to covid-19 – The BMJ
Study finds high viral loads in young children with mild to moderate Covid-19, raising questions about transmission
31 Jul, 2020 | 09:00h | UTCCommentaries: Young kids could spread COVID-19 as much as older children and adults, study suggests – Ann & Robert H. Lurie Children’s Hospital of Chicago AND Study finds higher viral load in young children, raising questions about how likely they are to transmit the coronavirus – CNN AND Children May Carry Coronavirus at High Levels, Study Finds – The New York Times
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
31 Jul, 2020 | 08:57h | UTCSARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 – Nature
Commentaries: Could prior exposure to common cold viruses affect the severity of SARS-CoV-2 symptoms? – Charité – Universitätsmedizin Berlin AND Why some people who haven’t had Covid-19 might already have some immunity – CNN
Related Commentary on Twitter
Just out @nature: 35% of healthy people (#SARSCoV2 seronegative) have reactive SARSCoV2 CD4 T cells to spike protein, presumably d/t cross-reactive coronavirus exposurehttps://t.co/Xt5tuULuyU
Important implications for explaining variable response to infections & vaccine trials— Eric Topol (@EricTopol) July 29, 2020
Single-shot Ad26 vaccine protects against SARS-CoV-2 in monkeys
31 Jul, 2020 | 08:49h | UTCSingle-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques – Nature
Commentaries: Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys) – NPR AND Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2 – News Medical
‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
31 Jul, 2020 | 08:40h | UTC‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast – STAT
Things you should think about when you hear “vaccine by end of the year”
31 Jul, 2020 | 08:41h | UTCThings you should think about when you hear “vaccine by end of the year” – Health News Review
How does SARS-CoV-2 cause COVID-19?
31 Jul, 2020 | 08:38h | UTCHow does SARS-CoV-2 cause COVID-19? – Science
[Press release] Tocilizumab did not improve outcomes in hospitalized patients with severe COVID-19 associated pneumonia
30 Jul, 2020 | 10:52h | UTC
Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in monkeys
29 Jul, 2020 | 09:53h | UTC
Longitudinal analyses reveal immunological misfiring in severe COVID-19
29 Jul, 2020 | 09:33h | UTCLongitudinal analyses reveal immunological misfiring in severe COVID-19 – Nature
Commentary: Immune system variation can predict severe COVID-19 outcomes – Yale University
Assessing the extent of SARS-CoV-2 circulation through serological studies
28 Jul, 2020 | 07:46h | UTCAssessing the extent of SARS-CoV-2 circulation through serological studies – Nature Medicine